Brief: Seegene Allplex 2019-Ncov Assay Gets Expanded FDA Emergency Use Authorization
30/07/2020 13:42
July 30 (Reuters) - Seegene Inc 096530.KQ :
* SEEGENE ALLPLEX(TM) 2019-NCOV ASSAY (SARS-COV-2) GETS
EXPANDED
FDA EMERGENCY USE AUTHORIZATION
Source text for Eikon: ID:nPn3X67Cga
Further company coverage: 096530.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seegene
See all newsBrief: Seegene To Cancel 174 Billion Won Worth Of Own Shares
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier